UK to impose £2.20 per 10ml vaping duty from 2027, spurring industry changes

The British government revealed that a fresh Vaping Product Duty is slated to commence in April 2027, levying £2.20 on each 10 ml of e‑liquid sold. As outlined in a recent BBC Business article, this represents the inaugural instance of a volume‑based tax targeting vaping products.

Officials argue the levy aims to tackle public‑health issues, especially the growing trend of youngsters trying e‑cigarettes. By bringing the tax model nearer to those imposed on alcohol and tobacco, the government seeks to curb casual consumption while preserving a comparatively safer option for adult smokers.

Trade associations caution that the charge may markedly lift the cost of well‑known e‑liquid brands, possibly driving certain users back to traditional cigarettes or into the black market. Small‑scale producers, often working with razor‑thin margins, foresee a steep rise in expenses that could compel them to merge or leave the sector altogether.

Consumer watchdogs point out that steeper prices might yield mixed outcomes. Although price hurdles could dissuade newcomers—particularly youths—they may also impose a monetary burden on adult vapers using e‑cigarettes to quit. The government has signalled that proceeds from the duty will be allocated to smoking‑cessation initiatives, though the specifics are still being debated.

Experts liken the forthcoming levy to previous UK tobacco tax increases, which historically reduced smoking prevalence yet also encouraged illicit trade. Monitoring systems are slated to be introduced to observe any surge in illegal e‑liquid sales, and the Treasury has indicated that enforcement will be a key focus.

With the April 2027 rollout drawing near, sellers are already tweaking stock levels and price tactics. Certain retailers are pushing higher‑strength liquids, which could attract a lower effective tax per nicotine milligram, while others are looking at alternative offerings like heated‑tobacco devices that escape the present duty scope. The next few months should show how the sector adjusts to the new fiscal terrain and if the projected public‑health benefits materialise.